Exploration of the Shared Hub Genes and Biological Mechanism in Osteoporosis and Type 2 Diabetes Mellitus Based on Machine Learning

Overview

Journal Biochem Genet

Specialty Molecular Biology

Date 2023 May 4

PMID 37140844

Authors

Runhan Zhao

Chuang Xiong

Zenghui Zhao

Jun Zhang

Yanran Huang

Zhou Xie

Xiao Qu

Xiaoji Luo

Zefang Li

Affiliations

Soon will be listed here.

Abstract

A substantial amount of evidence suggests a close relationship between osteoporosis (OP) and Type 2 Diabetes Mellitus (T2DM), but the mechanisms involved remain unknown. Therefore, we conducted this study with the aim of screening for hub genes common to both diseases and conducting a preliminary exploration of common regulatory mechanisms. In the present study, we first screened genes significantly associated with OP and T2DM by the univariate logistic regression algorithm. And then, based on cross-analysis and random forest algorithm, we obtained three hub genes (ACAA2, GATAD2A, and VPS35) and validated the critical roles and predictive performance of the three genes in both diseases by differential expression analysis, receiver operating characteristic (ROC) curves, and genome wide association study (GWAS) analysis. Finally, based on gene set enrichment analysis (GSEA) and the construction of the miRNA-mRNA regulatory network, we conducted a preliminary exploration of the co-regulatory mechanisms of three hub genes in two diseases. In conclusion, this study provides promising biomarkers for predicting and treating both diseases and offers novel directions for exploring the common regulatory mechanisms of both diseases.

Citing Articles

Identification and experimental validation of programmed cell death- and mitochondria-associated biomarkers in osteoporosis and immune microenvironment.

Yang X, Zhang Z, Lu Y, Chen H, Wang H, Lin T Front Genet. 2024; 15:1439171.

PMID: 39130750 PMC: 11310001. DOI: 10.3389/fgene.2024.1439171.

References

Abdelli S, Abderrahmani A, Hering B, Beckmann J, Bonny C . The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis. Diabetologia. 2007; 50(8):1660-9. DOI: 10.1007/s00125-007-0704-2. View

Adil M, Khan R, Kalam A, Venkata S, Kandhare A, Ghosh P . Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies. Pharmacol Rep. 2017; 69(6):1328-1340. DOI: 10.1016/j.pharep.2017.05.008. View

Aoki C, Uto K, Honda K, Kato Y, Oda H . Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy. Lab Invest. 2013; 93(11):1170-83. DOI: 10.1038/labinvest.2013.105. View

Arthur J, Ley S . Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013; 13(9):679-92. DOI: 10.1038/nri3495. View

Becerra-Tomas N, Estruch R, Bullo M, Casas R, Diaz-Lopez A, Basora J . Increased serum calcium levels and risk of type 2 diabetes in individuals at high cardiovascular risk. Diabetes Care. 2014; 37(11):3084-91. DOI: 10.2337/dc14-0898. View

Bruno G, Runzo C, Cavallo-Perin P, Merletti F, Rivetti M, Pinach S . Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy. Diabetes Care. 2005; 28(11):2613-9. DOI: 10.2337/diacare.28.11.2613. View

Burghardt A, Issever A, Schwartz A, Davis K, Masharani U, Majumdar S . High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010; 95(11):5045-55. PMC: 2968722. DOI: 10.1210/jc.2010-0226. View

Canela-Xandri O, Rawlik K, Tenesa A . An atlas of genetic associations in UK Biobank. Nat Genet. 2018; 50(11):1593-1599. PMC: 6707814. DOI: 10.1038/s41588-018-0248-z. View

Choi S, Son Y, Yun J, Kim S . Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways. Evid Based Complement Alternat Med. 2012; 2012:810563. PMC: 3447376. DOI: 10.1155/2012/810563. View

10.

Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M . Deciphering miRNAs' Action through miRNA Editing. Int J Mol Sci. 2019; 20(24). PMC: 6941098. DOI: 10.3390/ijms20246249. View

11.

Cotts K, Cifu A . Treatment of Osteoporosis. JAMA. 2018; 319(10):1040-1041. DOI: 10.1001/jama.2017.21995. View

12.

Dong C, Davis R, Flavell R . MAP kinases in the immune response. Annu Rev Immunol. 2002; 20:55-72. DOI: 10.1146/annurev.immunol.20.091301.131133. View

13.

Farr J, Drake M, Amin S, Melton 3rd L, McCready L, Khosla S . In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res. 2013; 29(4):787-95. PMC: 3961509. DOI: 10.1002/jbmr.2106. View

14.

Ferrari S, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R . Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. 2018; 29(12):2585-2596. PMC: 6267152. DOI: 10.1007/s00198-018-4650-2. View

15.

Gar C, Rottenkolber M, Prehn C, Adamski J, Seissler J, Lechner A . Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes. Crit Rev Clin Lab Sci. 2017; 55(1):21-32. DOI: 10.1080/10408363.2017.1414143. View

16.

Hah Y, Kang H, Cho H, Shin S, Kim U, Park B . JNK signaling plays an important role in the effects of TNF-α and IL-1β on in vitro osteoblastic differentiation of cultured human periosteal-derived cells. Mol Biol Rep. 2013; 40(8):4869-81. DOI: 10.1007/s11033-013-2586-3. View

17.

Hamann C, Goettsch C, Mettelsiefen J, Henkenjohann V, Rauner M, Hempel U . Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am J Physiol Endocrinol Metab. 2011; 301(6):E1220-8. DOI: 10.1152/ajpendo.00378.2011. View

18.

Hofbauer L, Brueck C, Singh S, Dobnig H . Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007; 22(9):1317-28. DOI: 10.1359/jbmr.070510. View

19.

Holman N, Young B, Gadsby R . Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. Diabet Med. 2015; 32(9):1119-20. DOI: 10.1111/dme.12791. View

20.

Janghorbani M, van Dam R, Willett W, Hu F . Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007; 166(5):495-505. DOI: 10.1093/aje/kwm106. View